Literature DB >> 26099587

Expression of the Oligopeptide Permease Operon of Moraxella catarrhalis Is Regulated by Temperature and Nutrient Availability.

Megan M Jones1, Timothy F Murphy2.   

Abstract

Moraxella catarrhalis causes otitis media in children and exacerbations of chronic obstructive pulmonary disease in adults. Together, these two conditions contribute to enormous morbidity and mortality worldwide. The oligopeptide permease (opp) ABC transport system is a nutritional virulence factor important for the utilization of peptides. The substrate binding protein OppA, which binds peptides for uptake, is a potential vaccine antigen, but little was known about the regulation of gene expression. The five opp genes oppB, oppC, oppD, oppF, and oppA are in the same open reading frame. Sequence analysis predicted two promoters, one located upstream of oppB and one within the intergenic region between oppF and oppA. We have characterized the gene cluster as an operon with two functional promoters and show that cold shock at 26°C for ≤ 0.5 h and the presence of a peptide substrate increase gene transcript levels. Additionally, the putative promoter upstream of oppA contributes to the transcription of oppA but is not influenced by the same environmental cues as the promoter upstream of oppB. We conclude that temperature and nutrient availability contribute to the regulation of the Opp system, which is an important nutritional virulence factor in M. catarrhalis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26099587      PMCID: PMC4534648          DOI: 10.1128/IAI.00597-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

Review 1.  ABC transporters: from microorganisms to man.

Authors:  C F Higgins
Journal:  Annu Rev Cell Biol       Date:  1992

Review 2.  ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies.

Authors:  Helen S Garmory; Richard W Titball
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

3.  Molecular characterization of group A streptococcal (GAS) oligopeptide permease (opp) and its effect on cysteine protease production.

Authors:  A Podbielski; B Pohl; M Woischnik; C Körner; K H Schmidt; E Rozdzinski; B A Leonard
Journal:  Mol Microbiol       Date:  1996-09       Impact factor: 3.501

4.  Respiratory infections caused by Branhamella catarrhalis. Selected epidemiologic features.

Authors:  F A Sarubbi; J W Myers; J J Williams; C G Shell
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

5.  Oligopeptide permease in Borrelia burgdorferi: putative peptide-binding components encoded by both chromosomal and plasmid loci.

Authors:  James L Bono; Kit Tilly; Brian Stevenson; Dan Hogan; Patricia Rosa
Journal:  Microbiology (Reading)       Date:  1998-04       Impact factor: 2.777

6.  Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.

Authors:  Timothy F Murphy; Aimee L Brauer; Brydon J B Grant; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

7.  The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis.

Authors:  B Henrich; M Hopfe; A Kitzerow; U Hadding
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

8.  Effects of oligopeptide permease in group a streptococcal infection.

Authors:  Chih-Hung Wang; Chia-Yu Lin; Yueh-Hsia Luo; Pei-Jane Tsai; Yee-Shin Lin; Ming T Lin; Woei-Jer Chuang; Ching-Chuan Liu; Jiunn-Jong Wu
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

9.  A technique to measure the ability of the human nose to warm and humidify air.

Authors:  P Rouadi; F M Baroody; D Abbott; E Naureckas; J Solway; R M Naclerio
Journal:  J Appl Physiol (1985)       Date:  1999-07

10.  Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants.

Authors:  R A Bonnah; H Wong; S M Loosmore; A B Schryvers
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

View more
  4 in total

Review 1.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

2.  Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.

Authors:  Antonia C Perez; Antoinette Johnson; Ziqiang Chen; Gregory E Wilding; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 3.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 4.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.